Key statistics
On Tuesday, Co-Diagnostics Inc (C97:DUS) closed at 0.184, 0.00% above its 52-week low of 0.184, set on Dec 30, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.00 |
|---|---|
| High | 0.184 |
| Low | 0.184 |
| Bid | -- |
| Offer | -- |
| Previous close | 5.52 |
| Average volume | -- |
|---|---|
| Shares outstanding | 2.03m |
| Free float | 2.03m |
| P/E (TTM) | -- |
| Market cap | 4.77m USD |
| EPS (TTM) | -29.44 USD |
Data delayed at least 15 minutes, as of Dec 30 2025 12:15 GMT.
More ▼
Press releases
- Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
- Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
- Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
- Co-Diagnostics Announces Reverse Stock Split
- Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
- Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
- Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
- Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
- Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
- Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
More ▼
